Login
$WEAV
$7.40 +$0.01 (0.14%) Close

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Accounts receivable, net
Deferred contract costs, net
Prepaid expenses and other current assets
Total current assets
Non-current assets:
Property and equipment, net
Operating lease right-of-use assets
Finance lease right-of-use assets
Deferred contract costs, net, less current portion
Intangible assets, net
Goodwill
Other non-current assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
Accrued and other current liabilities
Deferred revenue
Current portion of operating lease liabilities
Current portion of finance lease liabilities
Current portion of long-term debt
Total current liabilities
Non-current liabilities:
Other long-term liabilities
Operating lease liabilities, less current portion
Finance lease liabilities, less current portion
Long-term debt
Total liabilities
Redeemable convertible preferred stock, $0.00001 par value per share; zero and 43,836,109 shares authorized, issued and outstanding as of December 31, 2021 and 2020, respectively; liquidation preference of zero and $159,073 as of December 31, 2021 and 2020, respectively
Stockholders' equity:
Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized, zero shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock outstanding (in shares)
Common stock, $0.00001 par value per share; 500,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 79,913,403 and 78,353,381 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' equity
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support